Topographic metabolic map of head and neck squamous cell carcinoma using 18F-FDG PET and CT image fusion

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 100, Issue 5, 2005, Pages 619-625

  Dos Santos, Denise Takehana ^a   Pereira Lima, Eduardo Nóbrega ^b   Chojniak, Rubens ^b   Paraiso Cavalcanti, Marcelo Gusmão ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Cancer Hospital

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; GLUCOSE; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; HEAD AND NECK TUMOR; HUMAN; METABOLISM; METHODOLOGY; NOSE CAVITY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; FLUORODEOXYGLUCOSE F18; GLUCOSE; HEAD AND NECK NEOPLASMS; HUMANS; NASAL CAVITY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 26944455199     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2005.02.076     Document Type: Article

References (21)

1. M.G.P. Cavalcanti, and M.W. Vannier Measurement of the volume of oral tumors by three-dimensional spiral computed tomography Dentomaxillofac Radiol 29 2000 35 40
2. T. Beyer, D.W. Townsend, T. Brun, P.E. Kinahan, M. Charron, and R. Roddy A combined PET/CT scaner for clinical oncology J Nucl Med 41 2000 1369 1379
3. G. Lucignani, B.A. Jereczek-Fossa, and R. Orechia The role of molecular imaging in precision radiation therapy for target definition, treatment planning optimisation and quality control Eur J Nucl Med Mol Imaging 31 2004 1059 1063
4. 18F-FDG detection with a dual-head coincidence camera: a review Eur J Nucl Med 28 2001 663 678
5. W.L. Wong, K. Ussain, E. Chevretton, D.J. Hawkes, H. Baddeley, and M. Maisey Validation and clinical application of computer-combined computed tomography and positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose head and neck images Am J Surg 172 1996 628 632
6. Y. Anzai, W.R. Carroll, D.J. Quint, C.R. Bradford, S. Minoshima, and G.T. Wolf Recurrence of head and neck cancer after surgery of irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses Radiology 200 1996 135 141
7. 67Ga SPECT in evaluation of lymphoma: comparative study Radiology 227 2003 353 360
8. Wong FCL, Kim EE. Molecular imaging in oncology. Head and neck tumors. 1st ed. New York: Springer; 2000. p. 231-42.
9. 18F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer Annals Surg 236 2002 208 217
10. O.H. Beahrs, D.E. Henson, R.V.P. Hutter, and M.H. Myers Manual for staging of cancer. American Joint Committee on Cancer 3rd ed. 1988 Lippincott Philadelphia
11. P.S. Conti, D.L. Lilien, and K.P.E.T. Hawley [F-18]-FDG in oncology. A clinical update Nucl Med Biol 23 1996 717 735
12. R. Hemingway, W. Wong, E.B. Chevretton, and M. McGurk The use of positron emission tomography in the evaluation of orofacial malignancy and disease Br Dent J 181 1996 250 253
13. G. Majno, and I. Joris Cells, tissues and disease E.E. Kim E.F. Jackson Principles of general pathology 1996 Springer New York, NY 768 775
14. M.P. Stokkel, C.H. Terhard, G.J. Hordijk, and P.P. van Rijk The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography Eur J Nucl Med 26 1999 767 773
15. M. Pai, C.H. Park, J.H. Suh, and J.H. Koh Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer Clin Nucl Med 24 1999 495 500
16. M. Zimny, B. Nowak, E. Di Martino, S. Jaenicke, and U. Cremerius Hybrid PET vs. conventional imaging in the diagnosis of head and neck tumors J Nucl Med 41 2000 292P
17. E. Di Martino, B. Novak, and G.A. Krombach Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18F-FDG positron emission tomography (PET) Laryngo Rhino Otol 79 2000 201 206
18. E.E. Kim Imaging strategies and perspectives in oncology E.E. Kim E.F. Jackson Molecular imaging in oncology. head and neck tumors 2000 Springer New York, NY 13 15
19. S.S. Gambhir, J. Czernin, J. Schwimmer, D.H.S. Silverman, R.E. Coleman, and M.E. Phelps A tabulated summary of the FDG PET literature J Nucl Med 42 2001 1S 93S
20. I. Ak, M.P. Stockkel, and E.K. Pauwels Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology: part II: the clinical value in detecting and staging primary tumours J Cancer Res Clin Oncol 126 2000 560 574
21. 18F-FDG PET and hexokinase-II and glucose transporter-1 expression in pancreatic cancer J Nucl Med 43 2002 173 180